Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

NCT00006450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Brain Tumor

Interventions

DRUG: Phenylbutyrate

Sponsor

National Cancer Institute (NCI)